Company Overview of Ception Therapeutics, Inc.
Ception Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes new drugs. It offers Reslizumab for eosinophilic inflammatory conditions. The company also provides Anti-TNF, a class of small molecule anti-TNF receptor agents with the potential to be orally administered. Ception Therapeutics, Inc. was founded in 2004 and is based in Malvern, Pennsylvania. As of April 5, 2010, Ception Therapeutics, Inc. operates as a subsidiary of Cephalon, Inc.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2004
Key Executives for Ception Therapeutics, Inc.
Similar Private Companies By Industry
|Amneal Pharmaceuticals of New York, LLC||United States|
|Xenacare Holdings Inc.||United States|
|MiniVax, Inc.||United States|
|Honeywood, LLC||United States|
|Orahealth Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ception Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.